Search Results - "Siordiya, N T"

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Pustovaya, E I, Egorova, E K, Kovrigina, A M, Sudarikov, A B, Abdullaev, A O, Lomaia, E G, Siordiya, N T, Zaritskey, A Yu, Savchenko, V G

“…A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET)…”
Get full text

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS by Lisina, E. G., Siordiya, N. T., Butylin, P. A., Silyutina, A. A., Matyukhina, N. M., Senderova, O. M., Fokina, E. S., Ovsepyan, V. A., Lomaia, E. G., Zaritskiy, A. Yu

“…Introduction. JAK2V617F mutation is detected in approximately 50 % of patients with essential thrombocytosis (ET) and primary myelofibrosis (PMF). In 2013 most…”
Get full text